These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12532095)

  • 1. Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics.
    Anderson SD; Fitch K; Perry CP; Sue-Chu M; Crapo R; McKenzie D; Magnussen H
    J Allergy Clin Immunol; 2003 Jan; 111(1):45-50. PubMed ID: 12532095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics.
    Anderson SD; Sue-Chu M; Perry CP; Gratziou C; Kippelen P; McKenzie DC; Beck KC; Fitch KD
    J Allergy Clin Immunol; 2006 Apr; 117(4):767-73. PubMed ID: 16630932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta₂-agonists for exercise-induced asthma.
    Bonini M; Di Mambro C; Calderon MA; Compalati E; Schünemann H; Durham S; Canonica GW
    Cochrane Database Syst Rev; 2013 Oct; (10):CD003564. PubMed ID: 24089311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of inhaled formoterol in reversing bronchoconstriction.
    Rubin AS; Perin C; Pelegrin L; Fernandes JC; da Silva LC
    J Bras Pneumol; 2006; 32(3):202-6. PubMed ID: 17273608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spirometric Response to Bronchodilator and Eucapnic Voluntary Hyperpnea in Adults With Asthma.
    Haverkamp HC; Kaminsky DA; McPherson SM; Irvin CG
    Respir Care; 2021 Aug; 66(8):1282-1290. PubMed ID: 34006592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes.
    Holzer K; Anderson SD; Chan HK; Douglass J
    Am J Respir Crit Care Med; 2003 Feb; 167(4):534-7. PubMed ID: 12456381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta2-Agonists at the Olympic Games.
    Fitch KD
    Clin Rev Allergy Immunol; 2006; 31(2-3):259-68. PubMed ID: 17085798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma.
    Hermansen MN; Nielsen KG; Buchvald F; Jespersen JJ; Bengtsson T; Bisgaard H
    Chest; 2006 May; 129(5):1203-9. PubMed ID: 16685010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes.
    Simpson AJ; Bood JR; Anderson SD; Romer LM; Dahlén B; Dahlén SE; Kippelen P
    J Appl Physiol (1985); 2016 May; 120(9):1011-7. PubMed ID: 26846550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported Symptoms after Induced and Inhibited Bronchoconstriction in Athletes.
    Simpson AJ; Romer LM; Kippelen P
    Med Sci Sports Exerc; 2015 Oct; 47(10):2005-13. PubMed ID: 25710876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S; Hancox RJ
    Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised placebo controlled trial of beta agonist dose reduction in asthma.
    Harrison TW; Oborne J; Wilding PJ; Tattersfield AE
    Thorax; 1999 Feb; 54(2):98-102. PubMed ID: 10325911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.